ONCO Stock Catalyst: Onconetix, Inc. Enters Into Securities Purchase and Registration Rights Agreements

Onconetix, Inc. (Nasdaq: ONCO) announced on July 28, 2026, that it has entered into a Securities Purchase Agreement for the sale of common stock. Concurrently, the company also entered into a Registration Rights Agreement for the resale of common stock.

The agreements are supported by several filings including a Certificate of Designations authorizing the issuance of Series F Preferred Stock (EX-3.1), a Form of Securities Purchase Agreement (EX-10.1), a Form of Registration Rights Agreement (EX-10.2), a Form of ELOC Purchase Agreement (EX-10.3), and a Form of ELOC Registration Rights Agreement (EX-10.4).

Onconetix, Inc. has a free float of 140,624 shares.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.